Annie Curti

Director, Product Strategy & Launch Excellence (Hematology) Novartis

Annie Curti is a senior biopharmaceutical strategy and launch leader with more than 15 years of experience guiding commercialization, portfolio strategy, and launch execution across specialty and rare disease markets. As Director, Product Strategy & Launch Excellence – Hematology at Novartis, she leads cross-functional efforts that support high-stakes investment decisions, executive alignment, and go-to-market planning for priority assets. Annie is recognized for her expertise in launch strategy and has built her career helping organizations translate complex market dynamics into clear strategic direction. Prior to Novartis, she spent a decade at Deloitte, where she was a founding member of the Cell & Gene Therapy Practice and advised life sciences clients on growth strategy, commercialization, and innovation. She holds an MBA from Hult International Business School and a BA from Shanghai Normal University.

Pharma Launch Excellence Summit Conference Day 1: Wednesday September 30

11:00 AM Panel Discussion: Who Owns Launch Excellence? Building the Operating Model, Governance and Tools for Cross-Functional Execution

As the role evolves, definitions and responsibilities very widely. Without clarity, ownership and accountability can quickly break down. This roundtable session will cover:

• Defining launch excellence across organisational models

• Clarifying ownership across commercial, medical and operations

• Positioning launch excellence as a strategic function

Check out the incredible speaker line-up to see who will be joining Annie.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk